Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration announced today it has cleared tests from Cepheid and Hologic that detect chlamydia and gonorrhea for use with extragenital specimens, specifically from the throat and rectum.

These assays are the first to be cleared for extragenital indications for chlamydia and gonorrhea testing, the agency said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
23

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.